...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: US to shell out $1.2B for sup­plies of Mer­ck­'s po­ten­tial Covid-19 an­tivi­ral.

Fouremm ... gotta agree. I'm used to things taking longer than expected in the medical commercial market. But RVX has a rare talent for elongating process and timing. It's like other companies have a stockpile of administrative talent who know what to do like artists ... whereas RVX reminds me of myself doing a DIY project with instructions in Japanese and no pictures, and without the correct tools. So frustrating, activating my neurosis, sitting here watching all the other cars seeming fly by us ...

As much as I want my RVX stock to be worth $50-100 someday, sometimes (more and more) I just wish Don/BoD would just sell this company for $2-4b (instead of waiting for $8-10b or "whatever" the plan is) and just take the cash and run!!

Share
New Message
Please login to post a reply